TGFBR1 and cancer: Thus, targeting of TGF‐β receptors with soluble TGF‐β receptor II, small molecule ALK5 kinase inhibitors, or neutralizing TGF‐β1 antibodies have been reported to exhibit some therapeutic effect on cancer.2